When pharmaceutical giant Moderna recently announced plans for a vaccine production plant in the Montreal area, there was a lot of talk about the future of mRNA vaccines to fight other viruses. One big target is Respiratory Syncytial Virus. Our house doctor, Mike Simon, talks about RSV.